A promising new pancreatic cancer treatment pill has shown remarkable results, helping advanced patients live significantly ...

Acute pancreatitis is a common and costly gastrointestinal condition with significant risk of complications. The 2024 ...

The drug daraxonrasib nearly doubled the overall survival rates of pancreatic cancer patients. Here's how it works and who ...

(Corrects paragraph 5 to say "doubled" not "reduced") By Julie Steenhuysen CHICAGO, May 31 (Reuters) - Revolution Medicine's ...

For decades, scientists have been working to find solutions for pancreatic cancer, which is often diagnosed late and has few ...

While the drug is not a cure, researchers say it could meaningfully improve both the length and quality of life for patients ...

A DAD who threw up a litre of blood while sitting by the pool on holiday has told how medics blamed it on sunstroke. Peter ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Call it a run-in with reality. OpenAI executive Maggie Hott has crossed the finish lines of two Ironman triathlons and 21 ...

The drug, daraxonrasib, has been hailed as a breakthrough in managing the deadliest of all the major cancers.

New research shows a medication called daraxonrasib is helping people with advanced pancreatic cancer live longer.

The DNA changes responsible for a rare genetic condition causing babies to be born without a pancreas can now be identified ...